We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the...
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Fouad Namouni, M.D., to its...
CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following...
Trem-cel and VCAR33ALLO clinical trial data expected in the second half of 2024VCAR33ALLO granted Fast Track and Orphan Drug Designation by U.S. Food & Drug Administration Cash runway extends...
CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of March 1, 2024, the...
CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.09 | 5.26315789474 | 1.71 | 1.84 | 1.65 | 195583 | 1.74252322 | CS |
| 4 | -0.35 | -16.2790697674 | 2.15 | 2.22 | 1.65 | 224265 | 1.85412418 | CS |
| 12 | -0.53 | -22.7467811159 | 2.33 | 2.43 | 1.65 | 344078 | 2.02610589 | CS |
| 26 | -0.02 | -1.0989010989 | 1.82 | 3.1399 | 1.62 | 249496 | 2.08075125 | CS |
| 52 | -2.22 | -55.223880597 | 4.02 | 5.7 | 1.62 | 199333 | 2.65343492 | CS |
| 156 | -26.43 | -93.6238044633 | 28.23 | 29.99 | 1.62 | 151508 | 6.47089026 | CS |
| 260 | -40.22 | -95.7163255593 | 42.02 | 63.62 | 1.62 | 159680 | 10.57439342 | CS |
PonkenPlonken
2 weeks ago
Monksdream
1 month ago
glenn1919
2 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
